دورية أكاديمية

Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC

التفاصيل البيبلوغرافية
العنوان: Serum Antibody Against NY-ESO-1 and XAGE1 Antigens Potentially Predicts Clinical Responses to Anti–Programmed Cell Death-1 Therapy in NSCLC
المؤلفون: Ohue, Yoshihiro, Kurose, Koji, Karasaki, Takahiro, Isobe, Midori, Yamaoka, Takaaki, Futami, Junichiro, Irei, Isao, Masuda, Takeshi, Fukuda, Masaaki, Kinoshita, Akitoshi, Matsushita, Hirokazu, Shimizu, Katsuhiko, Nakata, Masao, Hattori, Noboru, Yamaguchi, Hiroyuki, Fukuda, Minoru, Nozawa, Ryohei, Kakimi, Kazuhiro, Oka, Mikio
المصدر: In Journal of Thoracic Oncology December 2019 14(12):2071-2083
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15560864
DOI:10.1016/j.jtho.2019.08.008